Evidence map›Paper›PMID 27298257›Full record

ArticleNucleic acids research2016

microRNA editing in seed region aligns with cellular changes in hypoxic conditions.

Giovanni Nigita, Mario Acunzo, Giulia Romano, Dario Veneziano, Alessandro Laganà, Marika Vitiello, Dorothee Wernicke, Alfredo Ferro, Carlo M Croce

Abstract read
In one paragraph

Article in Nucleic acids research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. RNA modifications in cancer and their detection: a review.Japanese journal of clinical oncology · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. ncRNA Editing: Functional Characterization and Computational Resources.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  6. Article
  7. Hypoxia-driven ncRNAs in breast cancer.Frontiers in oncology · 2023
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Genetic Variants ofGenes · 2022
    Article
  13. The Biological Function of MicroRNAs in Bone Tumors.International journal of molecular sciences · 2022
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Giovanni NigitaDepartment of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
Mario AcunzoDepartment of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA mario.acunzo@osumc.edu.
Giulia RomanoDepartment of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
Dario VenezianoDepartment of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
Alessandro LaganàDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA.
Marika VitielloDepartment of Clinicaland Molecular Biomedicine, University of Catania, Catania 95125, Italy.
Dorothee WernickeDepartment of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
Alfredo FerroDepartment of Structural & Functional Biology, University 'Federico II' of Naples, Naples 80126, Italy.
Carlo M CroceDepartment of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA carlo.croce@osumc.edu.

Funding

Tissue CoreP01CA081534 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KIPPS, THOMAS J · 2000 to 2016
$59.5M
Cancer Gene Discovery to Identify Targetable TargetsR35CA197706 · NCI · OHIO STATE UNIVERSITY · PI CROCE, CARLO M · 2015 to 2021
$6.4M
Identifying non-coding RNAs for early detection and prevention of lung cancerU01CA166905 · NCI · OHIO STATE UNIVERSITY · PI CROCE, CARLO M, PASS, HARVEY IRA · 2013 to 2017
$4.5M
MiRNAs/UCRs: biomarkers for cancer risk, tumor detection, progression & treatmentU01CA152758 · NCI · OHIO STATE UNIVERSITY · PI CROCE, CARLO M · 2010 to 2014
$1.8M
NCI NIH HHS P01 CA081534NCI NIH HHS R35 CA197706NCI NIH HHS U01 CA152758NCI NIH HHS U01 CA166905
6 · The paper itself

Abstract

RNA editing is a finely tuned, dynamic mechanism for post-transcriptional gene regulation that has been thoroughly investigated in the last decade. Nevertheless, RNA editing in non-coding RNA, such as microRNA (miRNA), have caused great debate and have called for deeper investigation. Until recently, in fact, inadequate methodologies and experimental contexts have been unable to provide detailed insights for further elucidation of RNA editing affecting miRNAs, especially in cancer.In this work, we leverage on recent innovative bioinformatics approaches applied to a more informative experimental context in order to analyze the variations in miRNA seed region editing activity during a time course of a hypoxia-exposed breast cancer cell line. By investigating its behavior in a dynamic context, we found that miRNA editing events in the seed region are not depended on miRNA expression, unprecedentedly providing insights on the targetome shifts derived from these modifications. This reveals that miRNA editing acts under the influence of environmentally induced stimuli.Our results show a miRNA editing activity trend aligning with cellular pathways closely associated to hypoxia, such as the VEGF and PI3K/Akt pathways, providing important novel insights on this poorly elucidated phenomenon.

Indexed as

Breast NeoplasmsCell HypoxiaFemaleGene-Environment InteractionGene Expression Regulation, NeoplasticHumansMCF-7 CellsMicroRNAsOncogene Protein v-aktPhosphatidylinositol 3-KinasesRNA EditingSignal TransductionVascular Endothelial Growth Factor AMicroRNAsOncogene Protein v-aktPhosphatidylinositol 3-KinasesVascular Endothelial Growth Factor AVEGFA protein, human

Identifiers

PMID27298257
PMCPMC4994866

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.